InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
T+90 hit rate
33%
T+90 mean return
+0.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Urist Marshall, Vice-Président Exécutif et Co-Responsable de la Recherche et des Investissements. Insider active across 1 company, notably Royalty Pharma plc. Cumulatively, 17 reports have been published. Breakdown: 0 buy · 12 sells. Total volume traded: €6.4m. Activity tracked since 7 May 2021. The latest transaction was filed on 14 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations17 total
13,684 shares@ US$53.06470.0020% mcap34.6% of flowClass A Ordinary SharesSEC:0001838139-26-000016
13,684 shares@ US$53.06470.0020% mcap11.4% of flowClass A Ordinary SharesSEC:0001838139-26-000016:0
36,484 shares0Class A Ordinary SharesSEC:0001802768-25-000031:0
23,333 shares@ US$37.296512.7% of flowClass A Ordinary SharesSEC:0001209191-23-012883:0
70,000 shares0Class A Ordinary SharesSEC:0001209191-23-010715:0
3,600 shares@ US$43.05142.4% of flowClass A Ordinary SharesSEC:0001209191-22-043282:0
23,333 shares@ US$43.18750.0031% mcap17.6% of flowClass A Ordinary SharesSEC:0001209191-22-039294:0
23,333 shares@ US$39.85070.0029% mcap16.4% of flowClass A Ordinary SharesSEC:0000899243-22-018222:0
70,000 shares0Class A Ordinary SharesSEC:0000899243-22-017656:0
16,566 shares@ US$45.13230.0020% mcap11.3% of flowClass A Ordinary SharesSEC:0000950103-21-008573:0
16,566 shares@ US$45.13239.6% of flowClass A Ordinary SharesSEC:0000950103-21-008573
14,566 shares@ US$41.52480.0016% mcap9.1% of flowClass A Ordinary SharesSEC:0000950103-21-008458:0
14,566 shares@ US$41.52487.7% of flowClass A Ordinary SharesSEC:0000950103-21-008458
1,900 shares@ US$41.08371.2% of flowClass A Ordinary SharesSEC:0000950103-21-007749
1,900 shares@ US$41.08370.0002% mcap1.2% of flowClass A Ordinary SharesSEC:0000950103-21-007749:0
49,700 shares0Class A Ordinary SharesSEC:0000950103-21-007079
49,700 shares0Class A Ordinary SharesSEC:0000950103-21-007079:0
17 of 17 declarations
About Urist Marshall
Marshall Urist is the Executive Vice President and Co-Head of Research and Investments at Royalty Pharma plc. He oversees the company's research and investment initiatives.
